News

While in some countries the COVID-19 pandemic moves towards a flattening curve, there is still a great need for medicines and medical supplies, especially in the low resource economies. Imres is proud to be able to help by supplying essential medicines and medical consumables. On request, we...

Dear Customer, This statement is in reference to the COVID-19 outbreak. The COVID-19 pandemic has affected many countries globally. In line with our mandate, Imres is supporting our partners in vulnerable countries and regions of the world that need support while increasing preparedness...

Dear Customer, This statement is in reference to the COVID-19 outbreak. The COVID-19 pandemic has affected many countries globally. In line with our mandate, we are supporting our partners in vulnerable countries and regions of the world that need support while increasing preparedness or...

From the 1st of January 2020, Leontien Ruttenberg has been appointed as Managing Director for Imres B.V., the Netherlands. Mr. Niek Zee, former Managing Director of Imres, has retired as of the 31st of December 2019. Niek will continue to serve on the Imres Supervisory Board. Leontien,...

As of February 9th, the European Falsified Medicines Directive (EU FMD) will become effective. The EU FMD is put in place to counteract the circulation of falsified medicines in Europe. All medicines require a unique identifier printed on each and every package. In addition, all medicines...

WHO urges governments to take action. An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from WHO. This means that people are taking medicines that fail to treat or prevent disease. Not only is...